NCT00512642 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Gordenin DA, Resnick MA
Yeast ARMs (DNA at-risk motifs) can reveal sources of genome instability. Mutat Res. 1998 May 25;400(1-2):45-58. Review.
Lam S, MacAulay C, Hung J, LeRiche J, Profio AE, Palcic B
Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J Thorac Cardiovasc Surg. 1993 Jun;105(6):1035-40.
Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL
Genetic alterations during colorectal-tumor development. N Engl J Med. 1988 Sep 1;319(9):525-32.

Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detection of Lung Cancer in High Risk Patients

Details for clinical trial NCT00512642

Clinical trial NCT00512642 - References